Skip to main navigation Skip to search Skip to main content

Preclinical models of Parkinson's disease.

  • Krys S. Bankiewicz
  • , Rosario Sanchez-Pernaute
  • , Yoshitsugu Oiwa
  • , Malgorzata Kohutnicka
  • , Alex Cummins
  • , Jamie Eberling

Research output: Contribution to journal › Article › peer-review

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder in which pigmented midbrain neurons progressively die producing a dopamine (DA) deficit in the striatum, which manifests as an akinetic movement disorder. Experimentally induced striatal DA depletion in animals is a valid model of parkinsonism. The capacity of certain substances to damage catecholaminergic neurons has been used extensively to produce DA deficiency in animals. This unit describes methods for inducing parkinsonism in nonhuman primates and rodents using the neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA). Additionally, procedures for evaluating the animals are presented.

Original languageEnglish
Pages (from-to)Unit1.8
JournalCurrent protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.]
VolumeChapter 1
StatePublished - Feb 2004

Fingerprint

Dive into the research topics of 'Preclinical models of Parkinson's disease.'. Together they form a unique fingerprint.

Cite this